Dong-Zhi Li

Dong-Zhi Li

Auto-generated profile, based on publicly available information

Dong-Zhi Li

Prenatal Diagnostic Center, Guangzhou Maternal and Neonatal Hospital, Guangzhou Women and Children's Medical Center, Guangzhou Medical College, Guangzhou, Guangdong, China

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2008 in Prenatal Diagnosis
Verified
Journal Article
Closed access
PDF file
CLCan Liao
Can Liao
DLDong‐Zhi Li
Dong‐Zhi Li

1 January 2006 in Hemoglobin
Verified
Journal Article
Closed access
DLDongzhi Li
Dongzhi Li
CLCan Liao
Can Liao
JLJian Li
Jian Li
YHYining Huang
Yining Huang
XXXingmei Xie
Xingmei Xie
SWShaoqing Wu
Shaoqing Wu
Beta-thalassemia (thal) is the most common genetic disease and is widely distributed in southern China. Prenatal diagnosis is needed to prevent the birth of thalassemic offspring in couples at-risk. This can be performed in the first or second trimester of pregnancy by DNA analysis using polymerase chain reaction (PCR). As there are more than 30 mutations causing beta-thal in Chinese, the point mutation detection by reverse dot-blot for common mutations together with direct DNA sequencing was developed for prenatal diagnosis. Using reverse dot-blot, we were able to offer complete diagnosis in 315 (99.4%) of 317 pregnancies. Only two fetuses needed the DNA sequencing technique for diagnosis. Of the 319 at-risk fetuses, 82 (25.7%) were found to be normal, 143 (44.8%) to be heterozygous for beta-thal and 94 (29.5%) to be affected with beta-thal. Therefore, the combination of reverse dot-blot with direct DNA sequencing can perform prenatal diagnosis by DNA analysis in almost all cases at- risk of beta-thal in southern China.

5 August 2005 in European Journal of Haematology
Verified
Journal Article
Closed access
PDF file
DLD. Z. Li
D. Z. Li
CLC. Liao
C. Liao
JLJ. Li
J. Li
XXX. M. Xie
X. M. Xie
YHY. N. Huang
Y. N. Huang
QWQ. C. Wu
Q. C. Wu

30 March 2010 in Hemoglobin
Verified
Journal Article
Closed access
PDF file
CLCan Liao
Can Liao
JZJian-Ying Zhou
Jian-Ying Zhou
XXXing-Mei Xie
Xing-Mei Xie
JLJian Li
Jian Li
RLRu Li
Ru Li
DLDong-Zhi Li
Dong-Zhi Li
Hb Constant Spring [Hb CS; α142, Term→Gln (TAA>CAA in α2)] is the most prevalent nondeletional α-thalassemia (α-thal) anomaly in southern China. In conjunction with α0-thal, it can cause severe Hb H (β4) disease. The present study was done to evaluate the efficiency of two diagnostic methods in detecting Hb CS. Automated high performance liquid chromatography (HPLC) and Sebia Capillarys 2, a capillary electrophoresis method, were applied to blood samples from 21 individuals with Hb CS trait. Of the 21 cases, all (100%) were detected by capillary electrophoresis, whereas only 16 (76.2%) were detected by HPLC. We concluded that the Sebia Capillarys 2 is the preferred method for Hb CS screening.

1 January 2007 in Hemoglobin
Verified
Journal Article
Closed access
CLCan Liao
Can Liao
QLQiuming Li
Qiuming Li
JWJiaxue Wei
Jiaxue Wei
QFQiong Feng
Qiong Feng
JLJian Li
Jian Li
DLDongzhi Li
Dongzhi Li
α-Thalassemia (thal) is one of the most common genetic diseases and is widely distributed in southern China. Fetuses with homozygous α0-thal, known as Hb Bart's (γ4) disease, usually die during the last trimester of gestation, and the affected pregnancies are frequently associated with serious maternal morbidity and mortality. Prenatal diagnosis is needed for early detection of this disease in couples at-risk. This can be performed by invasive fetal sampling or by serial ultrasonography to detect affected fetuses followed by invasive testing. Of 122 at-risk families who received prenatal testing, 98 (80.3%) chose ultrasonography, and 24 (19.7%) chose direct invasive testing. In all, 28 affected pregnancies were detected and terminated. Ultrasonography is now playing a major role in prenatal control of Hb Bart's disease in our region, and limits the invasive procedures to the few patients identified to be at high risk.

1 September 2006 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Closed access
DLDongzhi Li
Dongzhi Li
CLCan Liao
Can Liao
JLJian Li
Jian Li
XXXingmei Xie
Xingmei Xie
YHYining Huang
Yining Huang
JWJiaxue Wei
Jiaxue Wei